Your browser doesn't support javascript.
loading
Dinutuximab beta plus conventional chemotherapy for relapsed/refractory high-risk neuroblastoma: A single-center experience.
Olgun, Nur; Cecen, Emre; Ince, Dilek; Kizmazoglu, Deniz; Baysal, Birsen; Onal, Ayse; Ozdogan, Ozhan; Guleryuz, Handan; Cetingoz, Riza; Demiral, Ayse; Olguner, Mustafa; Celik, Ahmet; Kamer, Serra; Ozer, Erdener; Altun, Zekiye; Aktas, Safiye.
Afiliação
  • Olgun N; Department of Pediatric Oncology, Dokuz Eylul University Institute of Oncology, Izmir, Türkiye.
  • Cecen E; Department of Pediatric Oncology, Dokuz Eylul University Institute of Oncology, Izmir, Türkiye.
  • Ince D; Department of Pediatric Oncology, Dokuz Eylul University Institute of Oncology, Izmir, Türkiye.
  • Kizmazoglu D; Department of Pediatric Oncology, Dokuz Eylul University Institute of Oncology, Izmir, Türkiye.
  • Baysal B; Department of Pediatric Oncology, Dokuz Eylul University Institute of Oncology, Izmir, Türkiye.
  • Onal A; Department of Pediatric Oncology, Dokuz Eylul University Institute of Oncology, Izmir, Türkiye.
  • Ozdogan O; Department of Nuclear Medicine, Dokuz Eylul University School of Medicine, Izmir, Türkiye.
  • Guleryuz H; Department of Radiology, Dokuz Eylul University School of Medicine, Izmir, Türkiye.
  • Cetingoz R; Department of Radiation Oncology, Dokuz Eylul University School of Medicine, Izmir, Türkiye.
  • Demiral A; Department of Radiation Oncology, Dokuz Eylul University School of Medicine, Izmir, Türkiye.
  • Olguner M; Department of Pediatric Surgery, Dokuz Eylul University School of Medicine, Izmir, Türkiye.
  • Celik A; Department of Pediatric Surgery, Ege University School of Medicine, Izmir, Türkiye.
  • Kamer S; Department of Radiation Oncology, Ege University School of Medicine, Izmir, Türkiye.
  • Ozer E; Department of Pathology, Dokuz Eylul University School of Medicine, Izmir, Türkiye.
  • Altun Z; Department of Basic Oncology, Dokuz Eylul University Institute of Oncology, Izmir, Türkiye.
  • Aktas S; Department of Basic Oncology, Dokuz Eylul University Institute of Oncology, Izmir, Türkiye.
Front Oncol ; 12: 1041443, 2022.
Article em En | MEDLINE | ID: mdl-36620564

Texto completo: 1 Base de dados: MEDLINE Idioma: En Ano de publicação: 2022 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Idioma: En Ano de publicação: 2022 Tipo de documento: Article